Now, a freshly-minted member of the 40s club, Gemma's feeling her healthiest yet - and has wisdom aplenty to help you get ...

I had an image in my heart, in my head ... ‘I felt like I’d had a massage and cold-water therapy in one,’ she shares – ...

Sharma’s is one of many, ever-growing instances where quick commerce is transforming retail therapy in urban and suburban ...

Anyone can pick up this camera, shoot and print their photos with no fuss ... What's more, you don't have to worry about finding stock. You'll be considered a hero for wrapping this up under ...

Watch this incredible blind woman defy the odds and live her life to the fullest. Katelyn Wacker shared her experiences of how her glaucoma caused her to go blind but it doesn’t stop her from doing ...

With a market capitalization of $1.07 billion and its stock trading near 52-week lows ... and considerable challenges in the evolving gene therapy landscape. According to InvestingPro analysis ...

With a market capitalization of $1.07 billion and its stock trading near 52-week lows after a 60% decline year-to-date, the company faces both promising opportunities and considerable challenges in ...

could significantly boost investor confidence and drive substantial stock appreciation. Successful outcomes would validate the company's gene therapy platform and increase the probability of ...

While the holidays can be stressful, there are beautiful ways to help ease that stress and bring families together. An art ...

The stock’s fifty day simple moving average is $89.67 and its 200 day simple moving average is $89.85. U.S. Physical Therapy has a 1-year low of $76.18 and a 1-year high of $113.63. The stock ...

FDA approves Mesoblast's Ryoncil, the first U.S. MSC therapy, for children with steroid ... Price Action: MESO stock is up 42.60% at $17.47 during the premarket session at last check Thursday.

MyPEAK-1 is designed to test TN-201 as a one-time gene replacement therapy for a type of heart disease called MYBPC3-associated hypertrophic cardiomyopathy. Citing data from three patients in the ...